CAS: 141549-75-9 - Indisetron
Formula:C17H23N5O
InChI:InChI=1/C17H23N5O/c1-21-9-12-7-11(8-13(10-21)22(12)2)18-17(23)16-14-5-3-4-6-15(14)19-20-16/h3-6,11-13H,7-10H2,1-2H3,(H,18,23)(H,19,20)/t11-,12-,13+
InChI key:InChIKey=MHNNVDILNTUWNS-XYYAHUGANA-N
SMILES:O=C(NC1CC2N(C)C(CN(C)C2)C1)C3=NNC=4C=CC=CC43
- Synonyms:
- 1H-Indazole-3-carboxamide, N-(3,9-dimethyl-3,9-diazabicyclo[3.3.1]non-7-yl)-, endo-
- 1H-Indazole-3-carboxamide, N-[(7-endo)-3,9-dimethyl-3,9-diazabicyclo[3.3.1]non-7-yl]-
- 3,9-Diazabicyclo[3.3.1]nonane, 1H-indazole-3-carboxamide deriv.
- Indisetron [INN]
- N-(3,9-Dimethyl-endo-3,9-diazabicyclo(3.3.1)non-7-yl)-1H-indazole-3-carboxamide
- N-(3,9-dimethyl-3,9-diazabicyclo[3.3.1]non-7-yl)-1H-indazole-3-carboxamide
- N-[(7-endo)-3,9-Dimethyl-3,9-diazabicyclo[3.3.1]non-7-yl]-1H-indazole-3-carboxamide
- Unii-89Rbz66Nvc
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
Indisetron REF: 4Z-I-089001CAS: 141549-75-9 | - - - | To inquire | Tue 07 Jan 25 | |
Indisetron REF: TR-I532500CAS: 141549-75-9 | - - - | 350.00 €~2,382.00 € | Tue 18 Feb 25 | |
Indisetron REF: 3D-FI24573CAS: 141549-75-9 | Min. 95% | To inquire | Tue 18 Feb 25 |
Indisetron
CAS:141549-75-9
Formula:
C17H23N5O
Color and Shape:
White To Off-White Solid
Molecular weight:
313.41
Ref: 4Z-I-089001
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Indisetron
Controlled ProductCAS:141549-75-9
Applications A 5-HT3 receptor antagonist as an antiemetic agent. It is used for treatment of …
Formula:
C17H23N5O
Color and Shape:
Neat
Molecular weight:
313.4
Ref: TR-I532500
1mg | 350.00 € | ||
10mg | 2,382.00 € |
Estimated delivery in United States, on Tuesday 18 Feb 2025
Indisetron
CAS:141549-75-9
Indisetron is a drug that belongs to the group of low-potency antipsychotics. It is used …
Formula:
C17H23N5O
Purity:
Min. 95%
Molecular weight:
313.4 g/mol
Ref: 3D-FI24573
200mg | To inquire |
Estimated delivery in United States, on Tuesday 18 Feb 2025